Valacyclovir decreases plasma and genital viral loads in HSV-2/HIV-1 co-infected women
30 August 2008. Related: Conference reports, Women's health.
Women’s health
HPV genotypes in HIV-positive women in Zimbabwe and Uganda
30 August 2008. Related: Conference reports, Women's health.
Gender differences in viral load by CD4 count in men and women
12 June 2008. Related: Conference reports, Women's health.
Antiretroviral drug exposure in the female genital tract
2 October 2007. Related: Women's health.
Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women
2 October 2007. Related: Women's health.
Antiretroviral therapy exposure and incidence of diabetes mellitus in the Womens Interagency HIV Study
2 October 2007. Related: Women's health.
Protease inhibitors in pregnancy
3 July 2007. Related: Conference reports, Women's health.
Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV positive women
5 February 2007. Related: Women's health, Cancer and HIV.
Hormonal contraception and the risk of HIV acquisition
5 February 2007. Related: Women's health.
Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV positive women in Lusaka, Zambia
7 October 2006. Related: Conference reports, Women's health, Cancer and HIV.
Effect of herpes simplex therapy on genital and plasma HIV viral load
7 October 2006. Related: Conference reports, Women's health.
Genital tract pharmacokinetics of ten antiretroviral drugs in HIV-positive women
12 May 2006. Related: Conference reports, Women's health.
Initiation of ART leads to a rapid decline in cervical and vaginal HIV-1 RNA
12 May 2006. Related: Conference reports, Women's health.
Effect of HSV-2 treatment on HIV-1 genital shedding and plasma viral load
12 May 2006. Related: Conference reports, Women's health.
ARV treatment following singe dose nevirapine exposure
13 April 2006. Related: Conference reports, Women's health.
Effect of age/menopause on lopinavir and efavirenz concentrations in women
15 June 2005. Related: Conference reports, Women's health.
Women and HIV: research directions
6 November 2004. Related: Conference reports, Women's health.
Smoking during HIV infection may alter the natural history of HPV infection and increase the risk of cervical disease
29 July 2004. Related: Women's health.
Hypertension related to HAART in HIV-positive women
2 April 2004. Related: Conference reports, Women's health.
Testosterone therapy for women with low androgen levels or body weight
2 April 2004. Related: Conference reports, Women's health.
Intrauterine exposure to efavirenz
1 December 2003. Related: Conference reports, Women's health, Pregnancy, Side effects.
Antiviral dynamics and sex differences of AZT and 3TC triphosphate concentrations
1 November 2003. Related: Women's health.
Women have a greater immunological response to effective HAART
1 November 2003. Related: Women's health.
Single-dose nevirapine resistance in over 75% of mothers
1 September 2003. Related: Conference reports, Women's health, Pregnancy, Drug resistance.
Long-term persistence of distinct mutations in genital tract
1 September 2003. Related: Conference reports, Women's health, Drug resistance.
Nevirapine and MTCT: the single-dose backlash
1 September 2003. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy, Paediatric care.
Is stress associated with CIN progression in HIV-positive women?
1 July 2003. Related: Women's health, Cancer and HIV.
Gender differences in rates and reasons for stopping treatment
1 June 2003. Related: Conference reports, Treatment strategies, Women's health.
Maternal health, transmission and fertility
1 June 2003. Related: Conference reports, Women's health, Pregnancy.
Women: sexual function and relationships
1 June 2003. Related: Conference reports, Women's health, Side effects.
The impact of migration, race and ethnic diversity on healthcare delivery and clinical outcomes in the UK
1 June 2003. Related: Conference reports, Treatment access, Women's health.
PK studies reveal significant sex/gender differences
1 May 2003. Related: Conference reports, Women's health, PK and drug interactions.
Pediatric studies from 10th CROI
1 May 2003. Related: Conference reports, Women's health, Pregnancy, Paediatric care.
Conference has strong emphasis on women
1 April 2003. Related: Conference reports, Women's health, Lipodystrophy and metabolic complications, Cancer and HIV.
Reduced testosterone levels in HIV-positive women
1 April 2003. Related: Women's health, Lipodystrophy and metabolic complications, Other news.
European activists highlight importance of gender based research: women experience HIV differently
1 April 2003. Related: Women's health, Other news.
HAART enhances regression of cervical intraepithelial neoplasia in HIV-seropositive women
13 November 2002. Related: Women's health, Cancer and HIV.
In switch study, women twice as likely as men to discontinue HAART due to toxicities
11 July 2002. Related: Women's health, Side effects.
New research points the way for future treatment of women with HIV
11 June 2002. Related: Conference reports, Women's health.
Osteopenia seen in testosterone-deficient women with AIDS wasting
1 October 2001. Related: Women's health, Side effects, Lipodystrophy and metabolic complications.
HIV-positive women at high risk for pre-cancerous anal lesions
30 July 2001. Related: Women's health, Cancer and HIV.
A new women’s research agenda starts to see the light of day
30 June 2001. Related: Women's health.
Incidence of invasive cervical cancer in a cohort of HIV-infected women before and after the introduction of HAART
30 June 2001. Related: Women's health, Cancer and HIV.
HAART lowers CIN recurrence risk in HIV-positive women
17 May 2001. Related: Women's health, Coinfections and complications.
Seroconversion in Kenyan sex-workers linked with reduced HIV-specific immune response
17 March 2001. Related: Women's health.
Prevalence and correlates of anaemia in a large cohort of HIV-positive women
17 March 2001. Related: Women's health, Side effects.
Lactic acidosis in pregnant women receiving d4T (stavudine) and ddI (didanosine): EMEA issue statement
17 March 2001. Related: Women's health, Pregnancy, Side effects.
Anal HPV infection common in HIV positive and high-risk HIV negative women
17 March 2001. Related: Women's health.
HIV and women – overview
17 March 2001. Related: Conference reports, Women's health, Pregnancy.
US FDA and Bristol-Myers Squibb issue caution for combination HIV therapy with stavudine (d4T) and didanosine (ddI) in pregnant women
17 January 2001. Related: Treatment alerts, Women's health, Pregnancy.
HIV infection increases susceptibility to Chlamydia trachomatis pelvic inflammatory disease
17 January 2001. Related: Women's health.
Pregnancy does not accelerate progression of HIV-1 infection
17 January 2001. Related: Women's health, Pregnancy.
Human papillomavirus (HPV) may speed HIV progression
17 January 2001. Related: Women's health, Cancer and HIV.
Antiretroviral therapy in children, women and intravenous drug users
17 December 2000. Related: Conference reports, Women's health, Paediatric care.
Women initiate highly active antiretroviral therapy later than men
17 December 2000. Related: Women's health.
Association of vitamin A deficiency With cervical squamous intraepithelial lesions in HIV-positive women
17 December 2000. Related: Women's health.
Women and HIV: is it really a biological difference?
15 June 2000. Related: Women's health.